Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Other Non-Current Assets (2021 - 2025)

PAVmed (PAVM) has 5 years of Other Non-Current Assets data on record, last reported at $51000.0 in Q2 2025.

  • For Q2 2025, Other Non-Current Assets changed N/A year-over-year to $51000.0; the TTM value through Jun 2025 reached $51000.0, changed N/A, while the annual FY2024 figure was $208000.0, 81.87% down from the prior year.
  • Other Non-Current Assets reached $51000.0 in Q2 2025 per PAVM's latest filing, down from $208000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.1 million in Q4 2023 and bottomed at $51000.0 in Q2 2025.
  • Average Other Non-Current Assets over 5 years is $773454.5, with a median of $861000.0 recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: soared 54.62% in 2022, then crashed 81.87% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $725000.0 in 2021, then skyrocketed by 54.62% to $1.1 million in 2022, then rose by 2.32% to $1.1 million in 2023, then plummeted by 81.87% to $208000.0 in 2024, then plummeted by 75.48% to $51000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $51000.0 in Q2 2025, $208000.0 in Q4 2024, and $379000.0 in Q3 2024.